Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.

ABSTRACT:

Background

In 2016, the World Health Assembly adopted the resolution to eliminate viral hepatitis by 2030. This study aims to provide an overview of the burdens of hepatitis B virus (HBV) and hepatitis C virus (HCV) in Europe and their changes from 2010 to 2019 using estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.

Methods

We used GBD 2019 estimates of the burden associated with HBV-related and HCV-related diseases: acute hepatitis, cirrhosis and other chronic liver diseases, and liver cancer. We report total numbers and age-standardised rates per 100 000 for mortality, prevalence, incidence, and disability-adjusted life-years (DALYs) from 2010 to 2019. For each HBV-related and HCV-related disease and each measure, we analysed tempor

SUBMITTER: GBD 2019 Europe Hepatitis B & C Collaborators 

PROVIDER: S-EPMC11138131 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature